|
|
|
Name
|
Achillion Pharmaceuticals Inc. |
|
Address:
|
300 George St.
|
|
City:
|
New Haven
|
|
State:
|
CT
|
|
Zip:
|
06511
|
|
Phone
|
203-624-7000
|
|
Web
Site:
|
www.achillion.com
|
|
Fax:
|
624-7003
|
|
No. Employees
|
59
|
|
No. Researchers
|
48
|
|
Capitalization
|
$70,000,000
|
|
R&D Spending
|
$16,600,000
|
|
Major Investors
|
Atlas Venture, Shroder Ventures, Advent International, SG Capital, Bear Stearns Health Innoventures, Connecticut Innovations, Giliad Sciences
|
|
Strategic Alliances
|
Yale University, Entomed, Phytobiotech
|
|
Products
|
Research & development of anti-infectious agents &
anti-viral therapeutics
|
|
CFO
|
Mary Kay Fenton
|
|
Chief Scientific Research Officer
|
Milind Deshpande
|
|
Ownership
|
Private
|
|
CEO
|
Michael Kishbauch
|
|
Year Founded
|
2000
|
|
President
|
Michael Kishbauch
|
|
|
|
|
|
|
|
Human Resource Manager/Director
|
Daria Nettleton
|
|
|
